← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Yaupon Therapeutics, Inc.
Wayne, PA
$3,591,558
Total funding
7
Grants
Funding over time
peak $877K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$3,591,558 · 7
By mechanism
R42$2,008,872 · 2
R01$883,200 · 1
R41$372,935 · 3
R43$326,551 · 1
Investigators at Yaupon Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Nornicotine as a Treatment for Nicotine Addiction$547,093
R42 · FY2005 · DA
Norketamine for Treatment of Pain$509,167
R42 · FY2006 · DA
Norketamine for Treatment of Pain$369,203
R42 · FY2007 · DA
Nornicotine as a Treatment for Nicotine Addiction$367,805
R42 · FY2006 · DA
Novelty, Dopamine and Response to Amphetamine$294,600
R01 · FY2005 · DA
Novelty, Dopamine and Response to Amphetamine$294,600
R01 · FY2004 · DA
Novelty, Dopamine and Response to Amphetamine$294,000
R01 · FY2003 · DA
Lobeline Clinical Study in ADHD$250,000
R43 · FY2007 · MH
Norketamine for Treatment of Pain$215,604
R42 · FY2008 · DA
Nornicotine for Treatment of Pain$172,935
R41 · FY2007 · DA
Nornicotine Enantiomers and Nicotine Self Administration$100,000
R41 · FY2003 · DA
Norketamine for Treatment of Pain$100,000
R41 · FY2003 · DA
Lobeline Clinical Study in ADHD$76,551
R43 · FY2008 · MH